Article

Online CME: Imaging Renal Cell Carcinoma With Ultrasonography, CT and MRI

This CME activity highlights the techniques, advantages, and limitations of ultrasongraphy, CT, and MRI in evaluating renal masses.

Credits: 1.25Fee: NoneExpires: May 26, 2011

This CME activity, intended for primary care physicians, urologists, nephrologists, oncologists, radiologists, and other physicians who care for patients with renal masses, dovetails with the increased use of abdominal imaging techniques for a variety of indications and the consequent more frequent detection of renal cell carcinoma.

The review will highlight the techniques, advantages, and limitations of ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) in the evaluation of renal masses. It will also address the role of these imaging modalities in disease staging, as well as in surveillance of small masses and patients undergoing systemic therapy for advanced RCC.

Click here to access this third-party resource.

Related Videos
John Kane, MD | Credit: Northwell Health
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
4 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.